| Honorary Clinical Researcher, Consultant Medical Oncologist, Upper GI, Clinical Oncology department, University of Oxford, UK Chair, ESMO Guidelines Committee & member of the ESMO Council. Chair of the EORTC GI Trials Group. Honorary Clinical Researcher and consultant medical oncologist in upper GI oncology at Oxford University NHS Foundation trust with a research focus in oesophagogastric cancer. Dr Smyth’s interests are clinical trials and translational research, and she has worked on trial design and management of national and international investigator initiated trials. Dr. Smyth has published more than 200 peer-reviewed manuscripts in her field. She is a member of the European Society for Medical Oncology (ESMO) Upper GI Faculty, and is the Chair of the Guidelines Committee and member of the ESMO Council. She has previously served as the Chair of the ESMO OncologyPRO Working Group, Chair of the ESMO National Societies Committee and was Subject Editor for the most recent ESMO Gastric Cancer and Oesophageal Cancer Guidelines. Dr. Smyth is the current Chair of the EORTC GI Trials Group (2024-2027). In 2022, Dr. Smyth was a founding member of the UK & Ireland Oesophagogastric Cancer Group (UKIOG) and is a trustee of the UKIOG Charity. She is committed to furthering national and international collaboration in GI trials research and improving outcomes for patients with gastrointestinal cancer. |